Explore
Validate
LearnTissue expression
Cell line expression
Protein structure
GM2A
GM2 ganglioside activatorSAP-3
This gene encodes a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]
Top validated antibodies |
|||||
| Proteintech Group |  10864-2-AP |
4 references | Polyclonal |
WB
EL
IP
IHC
|
|
| LSBio | LS-C820590 |
Polyclonal |
WB
EL
IP
IHC
|
||
| Invitrogen Antibodies | 10864-2-AP |
Polyclonal |
WB
IP
IHC
OA
|
||
| NovoPro Bioscience Inc. | 111093 |
Polyclonal |
WB
EL
IP
IHC
|
||
| Cusabio Biotech Co., Ltd | CSB-PA02379A0Rb |
Polyclonal |
WB
EL
IP
IHC
|
||
All Antibodies
Filters
Enhanced validation Supportive data in Antibodypedia Data presented on provider website
Data in Antibodypedia (inconclusive) Recommended by provider